HER2 LOW BREAST CARCINOMA

Clinical trials for HER2 LOW BREAST CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new HER2 LOW BREAST CARCINOMA trials appear

Sign up with your email to follow new studies for HER2 LOW BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 2 Not yet finished but already full! 1

New hope for Tough-to-Treat breast cancer: drug combo trial aims to shrink tumors before surgery

Disease control Ongoing

This study is testing if adding a targeted drug called pyrotinib to standard chemotherapy before surgery works better than chemotherapy alone for people with a specific, high-risk type of early breast cancer. It will involve about 160 adults with hormone-positive, HER2-low breast…

Matched conditions: HER2 LOW BREAST CARCINOMA

Phase: PHASE3 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

HER2 LOW BREAST CARCINOMA

Get alerted when new HER2 LOW BREAST CARCINOMA trials appear

New hope for Tough-to-Treat breast cancer: drug combo trial aims to shrink tumors before surgery